Patrick Burns Rapuano, MD
Ophthalmology
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Radnor
View 1 additional location
Schedule onlineCall 610-902-2020
Headshot of Patrick Burns Rapuano, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Ophthalmology

Education and training

  • Residency: Wills Eye Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Rapuano is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Rapuano PB, Levin AV, Price JM, Myers JS, Lee D, Shukla AG. Early Experience with Netarsudil in Pediatric Patients: A Retrospective Case Series , Ophthalmol Glaucoma: 2021

Gonzalo-Gil E, Rapuano PB, Ikediobi U, Leibowitz R, Mehta S, Coskun AK, Porterfield JZ, Lampkin TD, Marconi VC, Rimland D, Walker BD, Deeks S, Sutton RE. Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members , Elife, 8: 2019,e44360

Rapuano PB, Mathews PM, Florakis GJ, Trokel SL, Suh LH. Corneal collagen crosslinking in patients treated with dextran versus isotonic hydroxypropyl methylcellulose (HPMC) riboflavin solution: a retrospective analysis , Eye Vis (Lond), 5(10): 2018,23

Mathews PM, De Rojas JO, Rapuano PB, Zemsky CJ, Florakis GJ, Trokel SL, Suh LH. Correlation of Scheimpflug densitometry changes with clinical outcomes after corneal crosslinking , J Cataract Refract Surg, 8(44): 2018,993-1002

Rapuano PB, Scanameo AH, Amponin DE, Paulose SA, Zyablitskaya M, Takaoka A, Suh LH, Nagasaki T, Trokel SL, Paik DC. Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis , Invest Ophthalmol Vis Sci, 59: 2018,332-337